Member Articles

Zimmer Biomet’s Near-Term Outlook Is Less Rosy Than Management Would Have You Believe

by

Shares of Zimmer Biomet are trading on lofty expectations and investors may be in for a shock should Zimmer Biomet continue to underperform during the second half of 2019. Foreign currency headwinds continue to grow as seen through the strength of the US Dollar Index during the third quarter of 2019. We like Zimmer Biomet’s deleveraging activities but think its share price has gotten ahead of itself given these rising headwinds, lack of top line growth, and deteriorating net operating cash flows. We are staying away from Zimmer Biomet. By Callum Turcan Zimmer Biomet (ZBH) makes medical devices and shares of ZBH yield 0.7% as of this writing. The company as it stands today was created through Zimmer Holdings acquiring … Read more

Carvana Seeks to Disrupt an Enormous Market

by

Image Source: Carvana Co. – IR Presentation By Callum Turcan Carvana Co. (CVNA) seeks to disrupt the used car and used light truck market in the United States as a leading e-commerce platform for used automobile sales. Perhaps best known for its “car vending machines” that are located in key metropolitan areas across the US, Carvana wants to fundamentally transform the way consumers buy, sell, and ultimately ascertain the proper value for used automobiles. Please note that Carvana does not pay out a common dividend at this time and is unlikely to do so in the foreseeable future given its negative free cash flows. Industry Overview The company noted that the US used auto sales market clocked in at $764 … Read more

Economic Commentary: US-Listed Chinese Names, 60-40 Stock-Bond Allocation and More

by

There’s an interesting saying that I came across recently…that hits at the most important component of any fiduciary approach: capital preservation. The saying was “Friends don’t let friends buy and hold.” We’ve always employed the Valuentum strategy, which we believe is much more promising than a traditional buy and hold strategy. – Brian Nelson, CFA The US-China trade war continues with reports indicating that the White House is considering delisting Chinese (FXI, MCHI, KWEB) companies on US exchanges. Let’s get more of the Valuentum’s team’s thoughts on these developments as well as other topics that have come to the fore. The latest alert to members is a great prompt to get the conversation started. The Valuentum Team: If we had … Read more

Our Reports on Stocks in the Medical Devices Industry

by

Image Source: U.S. Embassy Kyiv Ukraine Structure of the Medical Devices Industry The medical devices industry is heavily regulated and characterized by rapid technological change. Firms have been forced to compete on price due to economically-motivated buyers, consolidation among healthcare providers, and declining reimbursement rates. Healthcare reform measures have put additional pressure on procedure rates and market sizes. Still, firms can gain advantages by developing products with differentiated clinical outcomes or by creating patent-protected technology. Since most constituents hold important patents or trade secrets, we tend to like the group. We’ve optimized our health care coverage, the reports of which can be found here.

Our Reports on Stocks in the Energy Equipment & Services Industry

by

Image Source: Sollven Melindo Structure of the Energy Equipment Industry The energy equipment industry is heavily tied to the exploration and production (upstream) expenditures of oil and gas producers across the globe. Many industry constituents participate in a number of different market segments to offer a complete range of products/services to customers. The fortunes of the group are levered to energy prices (crude/natural gas), as higher prices make drilling projects more attractive and increase the demand for oilfield equipment and services. However, falling prices have an opposite effect, creating long boom and bust cycles. We’re neutral on the structure of the group. We’ve reallocated our resources to optimize our energy coverage. See here.

Alert — Chinese Stocks Hit the Skids

by

Image Source: Michael Vadon We don’t think US and China are anywhere close to any sort of meaningful trade agreement, regardless of what you hear from the White House. The latest move in this high-stakes trade war by the US may be to de-list Chinese stocks. This actually happening seems surreal given the implications on U.S. investors, but given weakness in US-listed Chinese names, the market is factoring in some probability of this occurring. By Brian Nelson, CFA On September 27, news hit the wires that indicated the White House is evaluating ways to curtail US investors’ “portfolio flows into China,” and that may include de-listing Chinese stocks on U.S. exchanges. Although the development comes amid the view that discussions … Read more

Dividend Increases/Decreases for the Week Ending September 27

by

Below we provide a list of firms that raised their dividends during the week ending September 27. The dividend reports of covered firms on this list will be updated shortly with the new information. To access our dividend reports use the ‘Symbol’ search box in our website header. Firms Raising Their Dividends This Week American Express (AXP): now $0.43 per share quarterly dividend, was $0.39. American Tower (AMT): now $0.95 per share quarterly dividend, was $0.92. Artesian Resources (ARTNA): now $0.2496 per share quarterly dividend, was $0.2459. BancFirst (BANF): now $0.32 per share quarterly dividend, was $0.30. City Holding (CHCO): now $0.57 per share quarterly dividend, was $0.53. CSB Bancorp (CSBB): now $0.28 per share quarterly dividend, was $0.26. DENTSPLY … Read more

Hold ‘em or Fold ‘em?

by

Let’s talk Cardinal Health, Hanesbrands, Ford and Verint in this piece. Our best ideas are ideas in the newsletter portfolios. Unlike other widely followed strategies, the Valuentum strategy likes to capture the entire pricing cycle on an idea. We don’t “operate” in ideas only below the ‘undervalued’ line, but we like to let our winners run to when they are overvalued and showing signs of technical/momentum deterioration. By Brian Nelson, CFA The most important quality of a Valuentum investor is patience. Once we add an idea to the newsletter portfolios, we don’t remove it once it starts to approach the lower bounds of the fair value estimate range. We generally don’t remove it at our fair value estimate either, and … Read more

Nike Posts a Solid Quarter and Issues Strong Guidance

by

Image Shown: Shares of Nike popped on September 25 after reporting a strong first quarter for fiscal 2020 and issuing favorable guidance for the full fiscal year. By Callum Turcan Nike (NKE) reported earnings for the first quarter of its fiscal 2020 (ended August 31) on September 24 and investors clearly liked what they saw. The sportswear company’s GAAP revenues climbed 7% year-over-year to $10.7 billion, a growth rate that would have been 10% on a constant currency basis given ongoing strength in the US dollar. Sales in the Greater China region rose by 27% year-over-year on a constant-currency basis, complemented by strong growth in EMEA (up 12% on a constant currency basis) and the Asian Pacific region (up 13% … Read more

Best Ideas Newsletter Portfolio Holding PayPal Can Thrive in a Post-eBay World

by

Image Source: PayPal Holdings Inc – IR Presentation By Callum Turcan We continue to like Best Ideas Newsletter portfolio holding PayPal Holdings (PYPL) as a way to gain exposure to the very attractive payment processing and financial technology industry, complementing our top-weighted Visa Inc (V) holding. Our fair value estimate stands at $125 per share of PYPL, and we love its ability to generate shareholder value (indicated by PayPal’s Very Attractive Economic Castle rating). The company does not pay out a common dividend at this time, however; if PayPal did, it could be a significant one given its strong free cash flows. From 2016-2018, PayPal’s annual free cash flows averaged $3.0 billion as the firm is very capex-lite (relatively speaking, … Read more